Long‐term evaluation of<scp>A</scp>stra<scp>T</scp>ech and<scp>B</scp>rånemark implants in patients treated with full‐arch bridges. Results after 12–15 years

Abstract

Treatment with Astra Tech TiOblast implants and Brånemark turned implants supporting full-arch bridges showed generally good clinical results with low numbers of implants with marginal bone loss indicative of peri-implantitis. No significant differences were found between the implant systems after 12-15 years in function.